MultiHance 529 mg/mL Injection, 15 mL Single-Dose Vial, 5 Vials/Pack

MultiHance — 529MG, Solution for injection, box of 5 × 15 mL vials

MultiHance (gadobenate dimeglumine) is a solution for injection for intravenous use. magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and pediatric patients (including term neonates), to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues. (1.1) magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease. (1.2) 1.1 Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) MultiHance is indicated for intravenous use in magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and pediatric patients (including term neonates), to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues. 1.2 Magnetic Resonance Angiography (MRA) of Renal and Aorto-ilio-femoral Vessels MultiHance is indicated for use in magnetic r

• Active ingredient or product type: gadobenate dimeglumine
• Strength/concentration: 529MG
• Dosage form and route: Solution for injection, Intravenous
• Exact package presentation: box of 5 × 15 mL vials
• NDC/item number: 0270-5164-14
• Manufacturer: BRACCO DIAGNOSTICS, INC.
• Storage/handling: Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Do not freeze.
• Status: Rx only

Important safety information: Hypersensitivity: anaphylactic/anaphylactoid reactions with cardiovascular, respiratory and cutaneous manifestations, ranging from mild to severe reactions including shock can occur.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.